TNSN95062A1 - Nouveaux derives dialkoxy-pyridinyle-benzimidazole - Google Patents
Nouveaux derives dialkoxy-pyridinyle-benzimidazoleInfo
- Publication number
- TNSN95062A1 TNSN95062A1 TNTNSN95062A TNSN95062A TNSN95062A1 TN SN95062 A1 TNSN95062 A1 TN SN95062A1 TN TNSN95062 A TNTNSN95062 A TN TNSN95062A TN SN95062 A TNSN95062 A TN SN95062A TN SN95062 A1 TNSN95062 A1 TN SN95062A1
- Authority
- TN
- Tunisia
- Prior art keywords
- compounds
- methyl
- pyridinyle
- dialkoxy
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LES COMPOSES NOUVEAUX OPTIQUEMENT PURS, SOIT, LES COMPOSES ENANTIOMERES SIMPLES (+)-5-CARBOMETHOXY-6-METHYL-2-[[(3,4-DIMETHOXY-2- PYRIDINYL) METHYL] SULFINYL] -1-H- BENZIMIDAZOLE ET (-) -5- CARBOMETHOXY-6-METHYL-2- [[(3,4-DIMETHOXY-2- PYRIDINYL) METHYL] SULFINYL] -1H-BENZIMIDAZOLE, OU DES SELS THERAPEUTIQUEMENT ACCEPTABLES DE CEUX-CI TELS QUE SELS NA+, Mg2+, Li+, K+, Ca2+ ET N+(R4), OU R EST UN GROUPE ALKYLE AVEC 1 A 4 ATOMES DE CARBONE, DES PROCEDES POUR LEUR PREPARATION ET DES PREPARATIONS PHARMACEUTIQUES CONTENANT LES COMPOSES COMME INGREDIENTS ACTIFS, AINSI QUE L'EMPLOI DES COMPOSES DANS DES PREPARATIONS PHARMACEUTIQUES, ET LES INTERMEDIAIRES OBTENUS EN PREPARANT LES COMPOSES
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9400511 | 1994-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN95062A1 true TNSN95062A1 (fr) | 1996-02-06 |
Family
ID=20392945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN95062A TNSN95062A1 (fr) | 1994-05-27 | 1994-05-29 | Nouveaux derives dialkoxy-pyridinyle-benzimidazole |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0712401A1 (fr) |
JP (1) | JPH09504557A (fr) |
CN (1) | CN1128997A (fr) |
AU (1) | AU2633095A (fr) |
BR (1) | BR9506235A (fr) |
CA (1) | CA2166988A1 (fr) |
CZ (1) | CZ24396A3 (fr) |
EE (1) | EE9600011A (fr) |
FI (1) | FI960367A (fr) |
HU (1) | HU9600005D0 (fr) |
IL (1) | IL113604A0 (fr) |
IS (1) | IS4321A (fr) |
MA (1) | MA23563A1 (fr) |
NO (1) | NO960268L (fr) |
PL (1) | PL312692A1 (fr) |
TN (1) | TNSN95062A1 (fr) |
WO (1) | WO1995032959A1 (fr) |
ZA (1) | ZA954125B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9423970D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
GB9423968D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Resolution |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
BR9915421A (pt) * | 1998-11-18 | 2001-08-07 | Astrazeneca Ab | Processo para a fabricação de sais alcalinos levemente solúveis ou menos solúveis de heterociclos de sulfinila substituìda, forma de dosagem farmacêutica, uso da mesma, método de tratamento de doenças gastrointestinais, e, processo para a fabricação de uma forma de dosagem farmacêutica. |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20080103169A1 (en) | 2006-10-27 | 2008-05-01 | The Curators Of The University Of Missouri | Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same |
US8247440B2 (en) | 2008-02-20 | 2012-08-21 | Curators Of The University Of Missouri | Composition comprising omeprazole, lansoprazole and at least one buffering agent |
CN102209529A (zh) | 2008-09-09 | 2011-10-05 | 阿斯利康(瑞典)有限公司 | 将药物组合物递送至有需要的患者的方法 |
CN102481293A (zh) | 2009-06-25 | 2012-05-30 | 阿斯利康(瑞典)有限公司 | 治疗具有发展nsaid-相关的溃疡的风险的患者的方法 |
EP2797600A4 (fr) | 2011-12-28 | 2015-09-16 | Pozen Inc | Compositions et procédés d'administration d'oméprazole plus acide acétylsalicylique améliorés |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0593463B1 (fr) * | 1990-06-20 | 1999-09-15 | Astra Aktiebolag | Derives de dialcoxy-pyridinyle-benzimidazole, procede de preparation et utilisation pharmaceutique de ces derives |
DE4035455A1 (de) * | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
-
1994
- 1994-05-29 TN TNTNSN95062A patent/TNSN95062A1/fr unknown
-
1995
- 1995-05-03 IL IL11360495A patent/IL113604A0/xx unknown
- 1995-05-11 CZ CZ96243A patent/CZ24396A3/cs unknown
- 1995-05-11 PL PL95312692A patent/PL312692A1/xx unknown
- 1995-05-11 HU HU9600005A patent/HU9600005D0/hu unknown
- 1995-05-11 WO PCT/SE1995/000519 patent/WO1995032959A1/fr not_active Application Discontinuation
- 1995-05-11 CN CN95190482A patent/CN1128997A/zh active Pending
- 1995-05-11 EE EE9600011A patent/EE9600011A/xx unknown
- 1995-05-11 EP EP95921187A patent/EP0712401A1/fr not_active Withdrawn
- 1995-05-11 CA CA002166988A patent/CA2166988A1/fr not_active Abandoned
- 1995-05-11 BR BR9506235A patent/BR9506235A/pt not_active Application Discontinuation
- 1995-05-11 JP JP8500730A patent/JPH09504557A/ja active Pending
- 1995-05-11 AU AU26330/95A patent/AU2633095A/en not_active Abandoned
- 1995-05-19 ZA ZA954125A patent/ZA954125B/xx unknown
- 1995-05-26 MA MA23901A patent/MA23563A1/fr unknown
-
1996
- 1996-01-17 IS IS4321A patent/IS4321A/is unknown
- 1996-01-23 NO NO960268A patent/NO960268L/no unknown
- 1996-01-26 FI FI960367A patent/FI960367A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI960367A0 (fi) | 1996-01-26 |
FI960367A (fi) | 1996-01-26 |
NO960268D0 (no) | 1996-01-23 |
EP0712401A1 (fr) | 1996-05-22 |
CZ24396A3 (en) | 1996-06-12 |
EE9600011A (et) | 1996-04-15 |
BR9506235A (pt) | 1997-08-12 |
CN1128997A (zh) | 1996-08-14 |
WO1995032959A1 (fr) | 1995-12-07 |
PL312692A1 (en) | 1996-05-13 |
IL113604A0 (en) | 1995-08-31 |
CA2166988A1 (fr) | 1995-12-07 |
JPH09504557A (ja) | 1997-05-06 |
HU9600005D0 (en) | 1996-03-28 |
MA23563A1 (fr) | 1995-12-31 |
IS4321A (is) | 1996-01-17 |
AU2633095A (en) | 1995-12-21 |
NO960268L (no) | 1996-01-23 |
ZA954125B (en) | 1995-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN95062A1 (fr) | Nouveaux derives dialkoxy-pyridinyle-benzimidazole | |
FR2421889A1 (fr) | Nouveaux derives d'acide thiazolidinecarboxylique-4 utiles comme medicaments antihypertenseurs et procedes pour leur preparation | |
EG17795A (en) | Process for preparing of 3-substituted 2-oxindole-1-carboxaimes as analgese and anti-inflammatory agents | |
KR930700482A (ko) | 신경보호성 안돌론 및 관련 유도체 | |
HUP9802937A2 (hu) | Benzo[g]kinolin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk | |
FR2439187A1 (fr) | Derives de 1-piperazine-carboxamides et -carbothioamides substitues, procede de preparation et compositions pharmaceutiques les contenant | |
TNSN91049A1 (fr) | Benzimidazoles substitues, procedes en vue de leur preparation, et leur emploi pharmaceutique | |
IL85988A (en) | 1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them | |
FR2438654A1 (fr) | Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose | |
FR2397403A1 (fr) | Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes | |
KR950005823A (ko) | 5-아미노-8-메틸-7-피롤리디닐퀴놀린-3-카르본산유도체 | |
YU47338B (sh) | Novo jedinjenje 4-fluoro-2-// (4-metoksi-2-piridinil)metil-/sulfinil/- 1h-benzimidazol i postupak za njegovo dobijanje | |
DE3568440D1 (en) | New (8s)-8-fluoroerythromycin derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them | |
TNSN95063A1 (fr) | Nouveaux benzimidazoles substitues | |
FR2440353A1 (fr) | Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament | |
HUP0004058A2 (hu) | Készítmények és eljárások biológiai membránok permeabilitásának reverzibilis növelésére | |
KR890009912A (ko) | 퀴놀린 유도체 및 그의 제조법 | |
FR2603587A1 (fr) | Derives de la 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonine (ou -1,4-benzoxazonine), procede pour leur preparation, medicaments les contenant et composes intermediaires | |
AU687023B2 (en) | Use of idazoxan and derivatives thereof in preparing a drug for treating parkinson's disease and its development | |
FR2355839A1 (fr) | Derives optiquement actifs d'acide benzoxazolyl-propionique, procede pour leur preparation et compositions therapeutiques les contenant | |
ES487631A1 (es) | Procedimiento para la obtencion de hexahidro-1,4-oxazepinas | |
FR2506767A1 (fr) | Derives heterocycliques d'amidoximes, leur preparation et leur application en therapeutique | |
ES8703441A1 (es) | Un procedimiento para la preparacion de agentes anti-hiperglicemicos de lactona. | |
JO1870B1 (en) | CO2 derivatives - pyridinyl benzimidazole innovative | |
FR2418792A1 (fr) | Derives de 3-azabicyclo(3.1.0)hexane, procede pour leur preparation, compositions biologiquement actives les contenant et procede herbicide les utilisant |